Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Current Leases (2019 - 2026)

Perspective Therapeutics' Current Leases history spans 8 years, with the latest figure at $1.1 million for Q1 2026.

  • On a quarterly basis, Current Leases rose 9.08% to $1.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 million, a 9.08% increase, with the full-year FY2025 number at $623000.0, down 34.9% from a year prior.
  • Current Leases hit $1.1 million in Q1 2026 for Perspective Therapeutics, up from $623000.0 in the prior quarter.
  • Over the last five years, Current Leases for CATX hit a ceiling of $1.1 million in Q1 2026 and a floor of $46000.0 in Q4 2023.
  • Historically, Current Leases has averaged $538500.0 across 5 years, with a median of $458000.0 in 2023.
  • The widest YoY moves for Current Leases: up 1980.43% in 2024, down 54.29% in 2024.
  • Tracing CATX's Current Leases over 5 years: stood at $272000.0 in 2022, then crashed by 83.09% to $46000.0 in 2023, then surged by 1980.43% to $957000.0 in 2024, then tumbled by 34.9% to $623000.0 in 2025, then skyrocketed by 71.59% to $1.1 million in 2026.
  • Business Quant data shows Current Leases for CATX at $1.1 million in Q1 2026, $623000.0 in Q4 2025, and $704000.0 in Q3 2025.